Fresenius Kabi Oncology reports net loss of Rs 63.63 crore in the December 2013 quarter

Explore Business Standard
Associate Sponsors
Co-sponsor

Sales decline 69.90% to Rs 45.27 crore
Net loss of Fresenius Kabi Oncology reported to Rs 63.63 crore in the quarter ended December 2013 as against net profit of Rs 48.36 crore during the previous quarter ended December 2012. Sales declined 69.90% to Rs 45.27 crore in the quarter ended December 2013 as against Rs 150.38 crore during the previous quarter ended December 2012. ParticularsQuarter EndedDec. 2013Dec. 2012% Var.Sales45.27150.38 -70 OPM %-81.1440.77 -PBDT-40.4769.04 PL PBT-48.8162.35 PL NP-63.6348.36 PLPowered by Capital Market - Live News
First Published: Feb 08 2014 | 1:35 PM IST